Lisa H. Lancaster, MD: Interstitial lung disease is a rare but not uncommon disease of scaring or inflammation that occurs in a space, or potential space, between the Avella and the capillaries or ...

Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on ...

The most common chronic progressive fibrosing ILD is IPF.1,2 PPF is another form of progressive fibrotic lung disease that ...

Please provide your email address to receive an email when new articles are posted on . Aging and tobacco smoke exposure increased the chances for interstitial lung abnormalities. These abnormalities ...

Please provide your email address to receive an email when new articles are posted on . Usual interstitial pneumonia was a common finding in lung biopsies of people evaluated for post-COVID-19 ...

Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma Ninety patients with advanced cancers who ...

Chemotherapy and radiation therapy may increase risk for interstitial pneumonitis (IP) in breast cancer patients, but there are little current population-based data on IP incidence in these patients.

Individuals in close proximity to care for interstitial lung disease (ILD) did not have significantly improved outcomes than those at a greater distance, based on data from more than 1600 individuals ...

A recent study validates that combining genetic and clinical data can predict the risk for pulmonary fibrosis in patients ...

Neil B. Minkoff, MD: Today we are discussing patient management of chronic fibrosing interstitial lung disease with progressive phenotype. I’m Dr Neil Minkoff, the chief medical officer of Coeus ...